Difference between revisions of "CD56"
Jump to navigation
Jump to search
(→Others) |
|||
| Line 14: | Line 14: | ||
===Others=== | ===Others=== | ||
*[[Rhabdomyosarcoma]].<ref name=pmid18487991>{{Cite journal | last1 = Bahrami | first1 = A. | last2 = Gown | first2 = AM. | last3 = Baird | first3 = GS. | last4 = Hicks | first4 = MJ. | last5 = Folpe | first5 = AL. | title = Aberrant expression of epithelial and neuroendocrine markers in alveolar rhabdomyosarcoma: a potentially serious diagnostic pitfall. | journal = Mod Pathol | volume = 21 | issue = 7 | pages = 795-806 | month = Jul | year = 2008 | doi = 10.1038/modpathol.2008.86 | PMID = 18487991 }}</ref> | |||
*[[Solid pseudopapillary tumour]]. | *[[Solid pseudopapillary tumour]]. | ||
*[[Follicular dendritic cell sarcoma]]. | *[[Follicular dendritic cell sarcoma]]. | ||
Revision as of 17:18, 13 September 2014
CD56 is a commonly available immunostain that is seen in a number of tumours. It is a sensitive marker of neuroendocrine differentiation.
Positive
Carcinomas
Lymphoid
- Acute myeloid leukemia.[2]
- Chronic myeloid leukemia.[2]
- Extranodal NK/T-cell lymphoma, nasal type.
- Hepatosplenic T-cell lymphoma.
Others
See also
References
- ↑ Kurokawa, M.; Nabeshima, K.; Akiyama, Y.; Maeda, S.; Nishida, T.; Nakayama, F.; Amano, M.; Ogata, K. et al. (May 2003). "CD56: a useful marker for diagnosing Merkel cell carcinoma.". J Dermatol Sci 31 (3): 219-24. PMID 12727026.
- ↑ 2.0 2.1 URL: http://www.nordiqc.org/Epitopes/CD56/CD56.htm. Accessed on: September 13, 2014.
- ↑ Bahrami, A.; Gown, AM.; Baird, GS.; Hicks, MJ.; Folpe, AL. (Jul 2008). "Aberrant expression of epithelial and neuroendocrine markers in alveolar rhabdomyosarcoma: a potentially serious diagnostic pitfall.". Mod Pathol 21 (7): 795-806. doi:10.1038/modpathol.2008.86. PMID 18487991.